MMP-13 Antibodies

Santa Cruz Biotechnology provides a broad selection of MMP-13 Antibodies for research focused on understanding matrix metalloproteinase-13 in various biological processes. MMP-13 Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Matrix metalloproteinase-13 functions as a key enzyme in the degradation of extracellular matrix components, playing a crucial role in tissue remodeling and repair. Research has shown matrix metalloproteinase-13's involvement in various pathological conditions, including arthritis, cancer metastasis, and cardiovascular diseases. Understanding matrix metalloproteinase-13 activity and regulation continues to be a focus in developing targeted therapeutic approaches. Investigating matrix metalloproteinase-13 expression patterns helps reveal its specific roles in different tissue types and disease states. Monitoring matrix metalloproteinase-13 levels provides valuable insights into disease progression and treatment effectiveness. Santa Cruz Biotechnology monoclonal antibodies for MMP-13 enable researchers worldwide to advance scientific understanding of disease mechanisms and potential therapeutic interventions.